dicyclohexyl-[2-(2-dicyclohexylphosphanylphenoxy)phenyl]phosphane

We are dicyclohexyl-[2-(2-dicyclohexylphosphanylphenoxy)phenyl]phosphane CAS:434336-16-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  dicyclohexyl-[2-(2-dicyclohexylphosphanylphenoxy)phenyl]phosphane
CAS.NO:434336-16-0
Molecular Formula:C36H52OP2
Molecular Weight:562.74500

Synonyms:
(Oxydi-2,1-phenylene)bis[dicyclohexyl] phosphine
(Oxybis(2,1-phenylene))bis(dicyclohexylphosphine)

Physical and Chemical Properties:
Density: /
Boiling point: 652.6±40.0 °C(Predicted)
Melting point: 140-146°C
Flash point:
Refractive index: /

Specification:
Appearance:White Powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

Related News: Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.3289-50-7 Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.3-Borono-5-fluorobenzoic acid Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.2-Bromo-4'-nitroacetophenone CAS:99-81-0 Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.